 |
|
Connexin 26 Studies in Patients With Sensorineural Hearing Loss
Margaret A. Kenna, MD;
Bai-Lin Wu, PhD;
Douglas A. Cotanche, PhD;
Bruce R. Korf, MD, PhD;
Heidi L. Rehm, PhD
Arch Otolaryngol Head Neck Surg. 2001;127:1037-1042.
Objective To determine the spectrum of connexin 26 (Cx26) mutations and their
phenotypes in children with sensorineural hearing loss (SNHL) or mixed hearing
loss (MHL).
Design Children with SNHL or MHL were prospectively tested for mutations in
the entire coding region of the Cx26 gene.
Patients Children with SNHL or MHL with no obvious etiology for the hearing loss.
Results Between December 1, 1998, and July 1, 2000, 107 patients with SNHL or
MHL from 99 families underwent Cx26 testing. Most patients were aged 1 week
to 16 years (61 boys and 46 girls). Thirty (30%) of 99 probands had Cx26 mutations:
biallelic mutations were detected in 18 (9 homozygous and 9 compound heterozygous)
and single mutations were detected in 12. Twelve previously reported mutations
(35delG, 167delT, E47X, L90P, M34T, G12V, V37I, R143W, V84L, V153I, V27I,
and 310del14) and 3 novel mutations (E129K, T8M, and N206S) were found. Hearing
loss in patients with biallelic Cx26 mutations ranged from unilateral high
frequency to bilateral profound. Four children, 2 with biallelic mutations,
had temporal bone abnormalities.
Conclusions Connexin 26 mutations are common in children with SNHL, and it is likely
that the homozygous and compound heterozygous mutations cause the SNHL. However,
pathogenicity is less certain when only a single Cx26 mutation is present.
Patients with biallelic Cx26 mutations had a slightly higher incidence of
milder hearing loss than in previous studies. Children with SNHL or MHL should
be tested for Cx26 mutations early in their evaluation.
From the Department of Otology and Laryngology, Harvard Medical School,
Boston, Mass (Drs Kenna and Cotanche); the Department of Otolaryngology and
Communication Disorders (Drs Kenna and Cotanche), the Genetics Diagnostic
Laboratory and the Department of Laboratory Medicine (Dr Wu), and the Laboratory
of Cellular and Molecular Hearing Research (Dr Cotanche), Children's Hospital
Boston; and Partner's Center for Human Genetics (Dr Korf) and the Department
of Neurobiology (Dr Rehm), Massachusetts General Hospital, Harvard Medical
School, Boston.
RELATED ARTICLE
Archives of Otolaryngology–Head & Neck Surgery Reader's Choice: Continuing Medical Education
Arch Otolaryngol Head Neck Surg. 2001;127(9):1146-1148.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Causation of Permanent Unilateral and Mild Bilateral Hearing Loss in Children
Tharpe and Sladen
TRENDS AMPLIF 2008;12:17-25.
ABSTRACT
The contribution of GJB2 mutations to slight or mild hearing loss in Australian elementary school children
Dahl et al.
J. Med. Genet. 2006;43:850-855.
ABSTRACT
| FULL TEXT
The Structural Context of Disease-causing Mutations in Gap Junctions
Fleishman et al.
J. Biol. Chem. 2006;281:28958-28963.
ABSTRACT
| FULL TEXT
Pathogenetic role of the deafness-related M34T mutation of Cx26
Bicego et al.
Hum Mol Genet 2006;15:2569-2587.
ABSTRACT
| FULL TEXT
GJB2 Gene Mutations in Cochlear Implant Recipients: Prevalence and Impact on Outcome
Lustig et al.
Arch Otolaryngol Head Neck Surg 2004;130:541-546.
ABSTRACT
| FULL TEXT
A genotype-phenotype correlation for GJB2 (connexin 26) deafness
Cryns et al.
J. Med. Genet. 2004;41:147-154.
ABSTRACT
| FULL TEXT
Genotypic and Phenotypic Correlations of DFNB1-Related Hearing Impairment in the Midwestern United States
Lim et al.
Arch Otolaryngol Head Neck Surg 2003;129:836-840.
ABSTRACT
| FULL TEXT
|
